Viscosupplementation for osteoarthritis of the knee: A key opinion leader panel discussion

Jack Bert, Jim Kenney, Nicholas A. Sgaglione, Scott McClelland, Robert Brophy, John Toth, Joseph Ruane, Yousaf Ali, Sheila Arquette, Vinod Dasa, Maria Lopes

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


With a sharp rise in the prevalence of osteoarthritis of the knee (OAK) in a younger population, new management strategies are needed to preserve mobility, improve patients' quality of life, and reduce the effects of potential disease-related comorbidities. Viscosupplementation with the use of hyaluronic acid (HA) injection is a treatment option for OAK that can provide lubrication and elastic shock absorption, leading to potential pain relief, improved function, and reduced stiffness. A key opinion leader (KOL) panel discussion was held December 3, 2016, with the objective of sharing opinions, ideas, information, and trends regarding OAK and the potential treatment and management offered by viscosupplementation. The panel concluded that viscosupplementation with HA injections presents a viable, cost-effective, and safe alternative for the treatment of OAK.

Original languageEnglish
Pages (from-to)S2-S7
JournalJournal of Managed Care and Specialty Pharmacy
Issue number6
StatePublished - Jun 2018


Dive into the research topics of 'Viscosupplementation for osteoarthritis of the knee: A key opinion leader panel discussion'. Together they form a unique fingerprint.

Cite this